Label Image (Lbl500903409)
Losartan Potassium
Product Images NDC 50090-3409
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-3409). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Losartan Fig1)
There are two treatments being compared, Atenolol and Losartan Potassium, with the primary endpoint being unknown. An adjusted risk reduction of 13%, with a p-value of 0.021, is mentioned. The table below shows study month increments of every 6 months.*
Figure 2 (Losartan Fig2)
Figure 3 (Losartan Fig3)
The text is not meaningful and seems to be a mix of random characters and symbols. It is not available.*
Figure-4 (Losartan Fig4)
The text displays information about the results of a clinical trial testing a drug called Losttan Potassium compared to a placebo. The table shows the percentage of patients who experienced an event during the trial, with 60% of patients on Losttan Potassium experiencing an event compared to 40% on the placebo. The risk reduction is noted as 16.1%, with a significance level of p=0.022.*
Chemical Structure (Losartan Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
